SLC12A5 and epilepsy: Moreover, impaired synaptic inhibition due to decreased KCC2 function has been demonstrated in many pathophysiological conditions, including epilepsy, spasticity and chronic pain (Boulenguez et al., 2010; Puskarjov et al., 2012; Gagnon et al., 2013).